APA (7th ed.) Citation

MG, C., K, M., L, E., L, M., L, P., E, G., . . . C, B. (2026). SENOPAUSE: Evaluation of an ASCO-Derived Clinical Proxy for Axillary Risk Stratification in a Retrospective Cohort. Clinical breast cancer, 26(4), 37. https://doi.org/10.1016/j.clbc.2026.02.013

Chicago Style (17th ed.) Citation

MG, Cazenave, et al. "SENOPAUSE: Evaluation of an ASCO-Derived Clinical Proxy for Axillary Risk Stratification in a Retrospective Cohort." Clinical Breast Cancer 26, no. 4 (2026): 37. https://doi.org/10.1016/j.clbc.2026.02.013.

MLA (9th ed.) Citation

MG, Cazenave, et al. "SENOPAUSE: Evaluation of an ASCO-Derived Clinical Proxy for Axillary Risk Stratification in a Retrospective Cohort." Clinical Breast Cancer, vol. 26, no. 4, 2026, p. 37, https://doi.org/10.1016/j.clbc.2026.02.013.